報價延遲最少15分鐘:2026/02/15 13:11 EST
常規時段
|
|
|
|
|
||||||||||||
|
|
|
|
|
75.04 
|
|
|
| 價值評估 |
|
盈利(現時/預測)
2.41/4.83
|
|
企業價值
19.32B
|
| 資產負債 |
|
每股賬面淨值
23.49
|
| 現金流量 |
|
現金流量率
0.06
|
| 損益表 |
|
收益
4.10B
|
|
每股收益
18.09
|
|
同行比較
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
同行比較之報價最少15分鐘延遲 (夜盤時段除外)
|
業務概覽
|
|||
| Hologic manufactures proprietary products for the healthcare needs of women. The company operates in four segments: diagnostics (44% of total sales), breast health (38%), surgical (16%), and skeletal health (2%). While the company traditionally focused on breast health, the acquisition of Gen-Probe put greater emphasis on commercial diagnostics. The United States accounts for the largest portion of the firm's revenue (69%), followed by Europe (20%), Asia (8%), and other international markets (3%). Hologic is headquartered in Bedford, Massachusetts. |
